Allergy Therapeutics half-year loss narrows on lower expenses
(Alliance News) - Allergy Therapeutics PLC on Monday said talks are underway regarding further financing as it said reduced costs helped trim its half-year loss. Read More
Price | 5.80p on 18-04-2025 | at 04:45:06
---|---|
Change | 0.00p 0% |
Buy | 6.00p |
Sell | 5.50p |
Buy / Sell AGY Shares |
Last Trade: | Buy 30,000.00 at 5.80p |
Day's Volume: | 0 |
Last Close: | 5.80p |
Open: | 0.00p |
ISIN: | GB00B02LCQ05 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 2.74p - 7.70p |
Market Capitalisation: | £276m |
VWAP: | 0.00p |
Shares in Issue: | 4,766m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 30,000 | 5.80p | Suspected BUY Trade |
16:35:18 - 17-Apr-25 |
Sell* | 20,000 | 5.70p | Uncrossing Trade |
11:00:29 - 17-Apr-25 |
Sell* | 42,000 | 5.505p | Ordinary |
08:25:30 - 17-Apr-25 |
Sell* | 2,000 | 5.505p | Ordinary |
08:19:10 - 17-Apr-25 |
Sell* | 65,000 | 5.70p | Uncrossing Trade |
16:35:08 - 16-Apr-25 |
Sell* | 20,000 | 5.70p | Uncrossing Trade |
14:00:01 - 16-Apr-25 |
Buy* | 15,000 | 5.80p | Suspected BUY Trade |
11:00:21 - 16-Apr-25 |
Sell* | 21,187 | 5.505p | Ordinary |
10:34:54 - 16-Apr-25 |
Buy* | 20,000 | 5.80p | Suspected BUY Trade |
09:00:10 - 16-Apr-25 |
Buy* | 166 | 6.00p | SI Trade |
08:00:40 - 16-Apr-25 |
Allergy Thera. (AGY) Regulatory News |
||
Date | Source | Headline |
---|---|---|
31st Mar 2025 7:00 am | RNS | Interim Results for six months ended 31 Dec 2024 |
27th Mar 2025 7:00 am | RNS | Advancement to final phase of PROTECT trial |
3rd Mar 2025 7:00 am | RNS | New Executive Long Term Incentive Awards |
27th Feb 2025 7:00 am | RNS-R | Presentations at 2025 AAAAI / WAO Joint Congress |
17th Feb 2025 7:00 am | RNS | Grass MATA MPL Phase III data published in Allergy |
14th Feb 2025 7:00 am | RNS | Grant of Options |
28th Jan 2025 7:00 am | RNS | Half Year Trading update |
22nd Jan 2025 7:00 am | RNS | PDMR Dealing and Total Voting Rights |
15th Jan 2025 7:00 am | RNS | Director/PDMR Shareholding |
19th Dec 2024 1:41 pm | RNS | Exercise of Options and Total Voting Rights |